It also draws on Telegra MD's own Terms of Service (telegramd.com/terms-of-service/, reviewed directly), current FDA and HHS reporting on testosterone, enclomiphene, gonadorelin, and anastrozole regulatory status (including the February 2025 FDA labeling action and the June 2026 HHS-announced request to remove the age-related "Limitation of Use"), and Endocrine Society clinical practice guidance on testosterone therapy
Medications like semaglutide and tirzepatide are game-changers in the revolutionary treatment of obesity and type 2 diabetes
In landmark trials such as SUSTAIN-6 and PIONEER-6, semaglutide demonstrated a significant reduction in major adverse cardiovascular events, including cardiovascular death, non-fatal heart attacks, and strokes, compared to placebo or standard care
Smaller, more frequent meals are easier to digest and reduce pressure on the stomach
Gender and gallstone disease